0001694244-17-000001.txt : 20170118
0001694244-17-000001.hdr.sgml : 20170118
20170118155033
ACCESSION NUMBER: 0001694244-17-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20170118
DATE AS OF CHANGE: 20170118
EFFECTIVENESS DATE: 20170118
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Osmol Therapeutics, Inc.
CENTRAL INDEX KEY: 0001694244
IRS NUMBER: 814728978
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-278697
FILM NUMBER: 17533404
BUSINESS ADDRESS:
STREET 1: 33 WHITNEY AVENUE
STREET 2: 3RD FLOOR
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
BUSINESS PHONE: 203-606-5600
MAIL ADDRESS:
STREET 1: 33 WHITNEY AVENUE
STREET 2: 3RD FLOOR
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
D
1
primary_doc.xml
X0707
D
LIVE
0001694244
Osmol Therapeutics, Inc.
33 WHITNEY AVENUE
3RD FLOOR
NEW HAVEN
CT
CONNECTICUT
06510
203-606-5600
DELAWARE
None
None
Corporation
true
2016
Brian
Dixon
c/o Osmol Therapeutics, Inc.
33 Whitney Avenue, Third Floor
New Haven
CT
CONNECTICUT
06510
Executive Officer
Director
Biotechnology
Decline to Disclose
- 06b
false
2016-12-21
false
true
true
true
false
0
3050000
550000
2500000
false
4
0
0
0
true
false
Osmol Therapeutics, Inc.
Brian Dixon
Brian Dixon
President
2017-01-18